ReP USP - Resultado da busca

Artigo de periodico
Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster (2024)
Machado, Rafael Rahal Guaragna ; Candido, Erika Donizette de Oliveira ; Aguiar, Andressa Simões ; Chalup, Vanessa Nascimento ; Sanches, Patricia Romão ; Dorlass, Erick Gustavo ; Amgarten, Deyvid Emanuel ; Pinho, João Renato Rebello ; Oliveira, Danielle Bruna Leal de
Source: Vaccines. Unidades: FM, ICB, BIOINFORMÁTICA
Subjects: MICROBIOLOGIA, COVID-19, INFECÇÕES POR CORONAVIRUS, VACINAS VIRAIS, VARIAÇÃO GENÉTICA, MUTAÇÃO GENÉTICA, ANTICORPOS, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Rafael Rahal Guaragna et al. Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster. Vaccines, v. 12, n. 2, 2024Tradução . . Disponível em: https://doi.org/10.3390/vaccines12020144. Acesso em: 04 jun. 2024.
APA
Machado, R. R. G., Candido, E. D. de O., Aguiar, A. S., Chalup, V. N., Sanches, P. R., Dorlass, E. G., et al. (2024). Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster. Vaccines, 12( 2). doi:10.3390/vaccines12020144
NLM
Machado RRG, Candido ED de O, Aguiar AS, Chalup VN, Sanches PR, Dorlass EG, Amgarten DE, Pinho JRR, Oliveira DBL de. Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster [Internet]. Vaccines. 2024 ; 12( 2):[citado 2024 jun. 04 ] Available from: https://doi.org/10.3390/vaccines12020144
Vancouver
Machado RRG, Candido ED de O, Aguiar AS, Chalup VN, Sanches PR, Dorlass EG, Amgarten DE, Pinho JRR, Oliveira DBL de. Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster [Internet]. Vaccines. 2024 ; 12( 2):[citado 2024 jun. 04 ] Available from: https://doi.org/10.3390/vaccines12020144
Artigo de periodico
Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: insights to the future (2024)
Souza, Milena Silva ; Farias, Jéssica Pires ; Santos, Robert Andreata ; Silva, Marianne Pereira; Brito, Ruth Dálety da Silva; Silva, Marcia Duarte Barbosa da; Peter, Cristina Mendes; Cirilo, Marcus Vinicius de França ; Luiz, Wilson Barros ; Birbrair, Alexander ; Vidal, Paloma Oliveira ; Amarante, Maria Fernanda Castro ; Candido, Erika Donizette de Oliveira ; Munhoz, Aldilene Silva ; Malta, Fernanda de Mello ; Dorlass, Erick Gustavo ; Machado, Rafael Rahal Guaragna ; Pinho, Joao Renato Rebello ; Oliveira, Danielle Bruna Leal de ; Maricato, Juliana Terzi ; Braconi, Carla Torres ; Janini, Luiz Mário Ramos ; Amorim, Jaime Henrique ; Ferreira, Luis Carlos de Souza ; Durigon, Edison Luiz
Source: Journal of Medical Virology. Unidade: ICB
Subjects: MICROBIOLOGIA, EPITOPOS, COVID-19, VACINAS VIRAIS, GLICOPROTEÍNAS DA MEMBRANA, ANTICORPOS, VARIAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Milena Silva et al. Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: insights to the future. Journal of Medical Virology, v. 96, n. 2, p. 9 , 2024Tradução . . Disponível em: https://doi.org/10.1002/jmv.29416. Acesso em: 04 jun. 2024.
APA
Souza, M. S., Farias, J. P., Santos, R. A., Silva, M. P., Brito, R. D. da S., Silva, M. D. B. da, et al. (2024). Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: insights to the future. Journal of Medical Virology, 96( 2), 9 . doi:10.1002/jmv.29416
NLM
Souza MS, Farias JP, Santos RA, Silva MP, Brito RD da S, Silva MDB da, Peter CM, Cirilo MV de F, Luiz WB, Birbrair A, Vidal PO, Amarante MFC, Candido ED de O, Munhoz AS, Malta F de M, Dorlass EG, Machado RRG, Pinho JRR, Oliveira DBL de, Maricato JT, Braconi CT, Janini LMR, Amorim JH, Ferreira LC de S, Durigon EL. Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: insights to the future [Internet]. Journal of Medical Virology. 2024 ; 96( 2): 9 .[citado 2024 jun. 04 ] Available from: https://doi.org/10.1002/jmv.29416
Vancouver
Souza MS, Farias JP, Santos RA, Silva MP, Brito RD da S, Silva MDB da, Peter CM, Cirilo MV de F, Luiz WB, Birbrair A, Vidal PO, Amarante MFC, Candido ED de O, Munhoz AS, Malta F de M, Dorlass EG, Machado RRG, Pinho JRR, Oliveira DBL de, Maricato JT, Braconi CT, Janini LMR, Amorim JH, Ferreira LC de S, Durigon EL. Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: insights to the future [Internet]. Journal of Medical Virology. 2024 ; 96( 2): 9 .[citado 2024 jun. 04 ] Available from: https://doi.org/10.1002/jmv.29416
Artigo de periodico
Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape (2023)
Oliveira, Jamille Ramos ; Ruiz, Cesar Manuel Remuzgo ; Machado, Rafael Rahal Guaragna ; Urbanski, Alysson Henrique ; Magawa, Jhosiene Yukari; Daher, Isabela Pazotti; Urbanski, Alysson Henrique ; Schmitz, Gabriela Justamante Händel ; Arcuri, Helen Andrade; Ferreira, Marcelo Alves ; Sasahara, Greyce Luri ; Medeiros, Giuliana Xavier de ; Silva Júnior, Roberto Carlos Vieira da ; Rosa, Daniela Santoro ; Nakaya, Helder Takashi Imoto ; Gadermaier, Gabriele; Coelho, Verônica ; Santos, Keity Souza ; Durigon, Edison Luiz ; Boscardin, Silvia Beatriz ; Schechtman, Deborah ; Cunha Neto, Edecio; Kalil Filho, Jorge Elias ; Coelho, Veronica Porto Carreiro de Vasconcellos
Source: Frontiers in Immunology. Unidades: ICB, IQ, FM, FCF
Subjects: MICROBIOLOGIA, PARASITOLOGIA, ANTICORPOS, COVID-19, VACINAS VIRAIS, EPITOPOS, IMUNOGLOBULINAS, VARIAÇÃO GENÉTICA, MUTAÇÃO GENÉTICA, PEPTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Jamille Ramos et al. Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape. Frontiers in Immunology, v. 13, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.1010105. Acesso em: 04 jun. 2024.
APA
Oliveira, J. R., Ruiz, C. M. R., Machado, R. R. G., Urbanski, A. H., Magawa, J. Y., Daher, I. P., et al. (2023). Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape. Frontiers in Immunology, 13, 1-15. doi:10.3389/fimmu.2022.1010105
NLM
Oliveira JR, Ruiz CMR, Machado RRG, Urbanski AH, Magawa JY, Daher IP, Urbanski AH, Schmitz GJH, Arcuri HA, Ferreira MA, Sasahara GL, Medeiros GX de, Silva Júnior RCV da, Rosa DS, Nakaya HTI, Gadermaier G, Coelho V, Santos KS, Durigon EL, Boscardin SB, Schechtman D, Cunha Neto E, Kalil Filho JE, Coelho VPC de V. Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape [Internet]. Frontiers in Immunology. 2023 ; 13 1-15.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3389/fimmu.2022.1010105
Vancouver
Oliveira JR, Ruiz CMR, Machado RRG, Urbanski AH, Magawa JY, Daher IP, Urbanski AH, Schmitz GJH, Arcuri HA, Ferreira MA, Sasahara GL, Medeiros GX de, Silva Júnior RCV da, Rosa DS, Nakaya HTI, Gadermaier G, Coelho V, Santos KS, Durigon EL, Boscardin SB, Schechtman D, Cunha Neto E, Kalil Filho JE, Coelho VPC de V. Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape [Internet]. Frontiers in Immunology. 2023 ; 13 1-15.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3389/fimmu.2022.1010105
Tese (Doutorado)
Soroprevalência da infecção pelos vírus Zika (ZIKV) e Dengue (DENV) em parturientes e transferência transplacentária de anticorpos anti-ZIKV e anti- DENV em neonatos na cidade de São Paulo, Brasil (2023)
Machado, Rafael Rahal Guaragna ; Durigon, Edison Luiz (Orientador)
Unidade: ICB
Subjects: MICROBIOLOGIA, ZIKA VÍRUS, DENGUE, ARBOVÍRUS, RECÉM-NASCIDO, ELISA, SOROS, ÁCIDOS NUCLEICOS, ANTICORPOS, IMUNOGLOBULINAS, REAÇÃO EM CADEIA POR POLIMERASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Rafael Rahal Guaragna. Soroprevalência da infecção pelos vírus Zika (ZIKV) e Dengue (DENV) em parturientes e transferência transplacentária de anticorpos anti-ZIKV e anti- DENV em neonatos na cidade de São Paulo, Brasil. 2023. Tese (Doutorado) – Universidade de São Paulo, São Paulo, 2023. Disponível em: https://www.teses.usp.br/teses/disponiveis/42/42132/tde-14092023-153844/. Acesso em: 04 jun. 2024.
APA
Machado, R. R. G. (2023). Soroprevalência da infecção pelos vírus Zika (ZIKV) e Dengue (DENV) em parturientes e transferência transplacentária de anticorpos anti-ZIKV e anti- DENV em neonatos na cidade de São Paulo, Brasil (Tese (Doutorado). Universidade de São Paulo, São Paulo. Recuperado de https://www.teses.usp.br/teses/disponiveis/42/42132/tde-14092023-153844/
NLM
Machado RRG. Soroprevalência da infecção pelos vírus Zika (ZIKV) e Dengue (DENV) em parturientes e transferência transplacentária de anticorpos anti-ZIKV e anti- DENV em neonatos na cidade de São Paulo, Brasil [Internet]. 2023 ;[citado 2024 jun. 04 ] Available from: https://www.teses.usp.br/teses/disponiveis/42/42132/tde-14092023-153844/
Vancouver
Machado RRG. Soroprevalência da infecção pelos vírus Zika (ZIKV) e Dengue (DENV) em parturientes e transferência transplacentária de anticorpos anti-ZIKV e anti- DENV em neonatos na cidade de São Paulo, Brasil [Internet]. 2023 ;[citado 2024 jun. 04 ] Available from: https://www.teses.usp.br/teses/disponiveis/42/42132/tde-14092023-153844/
Artigo de periodico
Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial (2022)
Sekine, Leo ; Arns, Beatriz ; Fabro, Bruna R.; Cipolatt, Murillo M.; Machado, Rafael Rahal Guaragna ; Durigon, Edison Luiz
Source: European Respiratory Journal. Unidade: ICB
Subjects: MICROBIOLOGIA, PLASMA, COVID-19, ESTUDOS RANDOMIZADOS, IMUNIZAÇÃO PASSIVA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEKINE, Leo et al. Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial. European Respiratory Journal, v. 59, n. 2, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1183/13993003.02076-2021. Acesso em: 04 jun. 2024.
APA
Sekine, L., Arns, B., Fabro, B. R., Cipolatt, M. M., Machado, R. R. G., & Durigon, E. L. (2022). Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial. European Respiratory Journal, 59( 2), 1-11. doi:10.1183/13993003.02076-2021
NLM
Sekine L, Arns B, Fabro BR, Cipolatt MM, Machado RRG, Durigon EL. Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial [Internet]. European Respiratory Journal. 2022 ; 59( 2): 1-11.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1183/13993003.02076-2021
Vancouver
Sekine L, Arns B, Fabro BR, Cipolatt MM, Machado RRG, Durigon EL. Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial [Internet]. European Respiratory Journal. 2022 ; 59( 2): 1-11.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1183/13993003.02076-2021
Artigo de periodico
Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) (2022)
Song, Alice Tung Wan ; Rocha, Vanderson Geraldo ; Mendrone Júnior, Alfredo ; Rodrigues, Rodrigo do Tocantins Calado de Saloma ; Santis, Gil Cunha De ; Benites, Bruno D. ; Lima, Carolina Costa ; Vargas, Taiani ; Marques, Leonardo da Silva ; Fernandes, Juliana C. ; Breda, Felipe C.; Wendel, Silvano ; Fachini, Roberta; Rizzo, Luiz V. ; Kutner, José Mauro ; Silva, Vivian Helena Iida Avelino da ; Machado, Rafael Rahal Guaragna ; Durigon, Edison Luiz ; Chevret, Sylvie ; Kallas, Esper Georges
Source: Lancet Regional Health. Americas. Unidades: FM, FMRP, ICB
Subjects: MICROBIOLOGIA, COVID-19, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, PLASMA, SANGUE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SONG, Alice Tung Wan et al. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI). Lancet Regional Health. Americas, v. 10, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.lana.2022.100216. Acesso em: 04 jun. 2024.
APA
Song, A. T. W., Rocha, V. G., Mendrone Júnior, A., Rodrigues, R. do T. C. de S., Santis, G. C. D., Benites, B. D., et al. (2022). Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI). Lancet Regional Health. Americas, 10, 1-10. doi:10.1016/j.lana.2022.100216
NLM
Song ATW, Rocha VG, Mendrone Júnior A, Rodrigues R do TC de S, Santis GCD, Benites BD, Lima CC, Vargas T, Marques L da S, Fernandes JC, Breda FC, Wendel S, Fachini R, Rizzo LV, Kutner JM, Silva VHIA da, Machado RRG, Durigon EL, Chevret S, Kallas EG. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) [Internet]. Lancet Regional Health. Americas. 2022 ; 10 1-10.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.lana.2022.100216
Vancouver
Song ATW, Rocha VG, Mendrone Júnior A, Rodrigues R do TC de S, Santis GCD, Benites BD, Lima CC, Vargas T, Marques L da S, Fernandes JC, Breda FC, Wendel S, Fachini R, Rizzo LV, Kutner JM, Silva VHIA da, Machado RRG, Durigon EL, Chevret S, Kallas EG. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) [Internet]. Lancet Regional Health. Americas. 2022 ; 10 1-10.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/j.lana.2022.100216
Artigo de periodico
Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil (2022)
Santos, Robert Andreata ; Machado, Rafael Rahal Guaragna ; Alves, Rúbens Prince dos Santos ; Sales, Natiely Silva ; Soares, Camila Pereira ; Rodrigues, Karine Bitencourt ; Andrade, Juliana Bannwart ; Fock, Ricardo Ambrósio ; Margarido, Paulo Francisco Ramos ; Carvalho, Cristiane Rodrigues Guzzo ; Boscardin, Silvia Beatriz ; Durigon, Edison Luiz ; Ferreira, Luís Carlos de Souza
Source: Frontiers in Cellular and Infection Microbiology. Unidades: HU, ICB, FCF, BIOTECNOLOGIA
Subjects: MICROBIOLOGIA, PARASITOLOGIA, COVID-19, TESTES SOROLÓGICOS, TRIAGEM, SERVIÇOS DE SAÚDE, ESTUDOS RETROSPECTIVOS, ANTICORPOS, ELISA, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Robert Andreata et al. Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil. Frontiers in Cellular and Infection Microbiology, v. 12, p. 1-8, 2022Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2022.787411. Acesso em: 04 jun. 2024.
APA
Santos, R. A., Machado, R. R. G., Alves, R. P. dos S., Sales, N. S., Soares, C. P., Rodrigues, K. B., et al. (2022). Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil. Frontiers in Cellular and Infection Microbiology, 12, 1-8. doi:10.3389/fcimb.2022.787411
NLM
Santos RA, Machado RRG, Alves RP dos S, Sales NS, Soares CP, Rodrigues KB, Andrade JB, Fock RA, Margarido PFR, Carvalho CRG, Boscardin SB, Durigon EL, Ferreira LC de S. Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12 1-8.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3389/fcimb.2022.787411
Vancouver
Santos RA, Machado RRG, Alves RP dos S, Sales NS, Soares CP, Rodrigues KB, Andrade JB, Fock RA, Margarido PFR, Carvalho CRG, Boscardin SB, Durigon EL, Ferreira LC de S. Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12 1-8.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3389/fcimb.2022.787411
Artigo de periodico
Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease (2022)
Srinivasan, Vasundara ; Brognaro, Hévila ; Prabhu, Prince R.; Souza, Edmarcia Elisa de ; Günther, Sebastian ; Reinke, Patrick Y. A.; Barra, Angélica Luana Carrilho ; Machado, Rafael Rahal Guaragna ; Durigon, Edison Luiz ; Wrenger, Carsten
Source: Communications Biology. Unidades: ICB, IFSC
Subjects: MICROBIOLOGIA, PARASITOLOGIA, ANTIVIRAIS, COVID-19, ATIVAÇÃO ENZIMÁTICA, ENZIMAS PROTEOLÍTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SRINIVASAN, Vasundara et al. Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease. Communications Biology, v. 5, p. 1-12, 2022Tradução . . Disponível em: https://doi.org/10.1038/s42003-022-03737-7. Acesso em: 04 jun. 2024.
APA
Srinivasan, V., Brognaro, H., Prabhu, P. R., Souza, E. E. de, Günther, S., Reinke, P. Y. A., et al. (2022). Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease. Communications Biology, 5, 1-12. doi:10.1038/s42003-022-03737-7
NLM
Srinivasan V, Brognaro H, Prabhu PR, Souza EE de, Günther S, Reinke PYA, Barra ALC, Machado RRG, Durigon EL, Wrenger C. Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease [Internet]. Communications Biology. 2022 ; 5 1-12.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1038/s42003-022-03737-7
Vancouver
Srinivasan V, Brognaro H, Prabhu PR, Souza EE de, Günther S, Reinke PYA, Barra ALC, Machado RRG, Durigon EL, Wrenger C. Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease [Internet]. Communications Biology. 2022 ; 5 1-12.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1038/s42003-022-03737-7
Artigo de periodico
Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: triple-blind clinical trial (2021)
Bertanha, Matheus ; Rodrigues, Lenize da Silva ; Mellucci Filho, Pedro Luciano ; Moroz, Andrei ; Pardini, Maria Inês de Moura Campos ; Sobreira, Marcone Lima ; Durigon, Edison Luiz ; Machado, Rafael Rahal Guaragna ; Carvalho, Cristiane Rodrigues Guzzo
Source: Medicine. Unidade: ICB
Subjects: MICROBIOLOGIA, ANTICOAGULANTES, POLISSACARÍDEOS, CORONAVIRUS, DOENÇAS RESPIRATÓRIAS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, COVID-19, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERTANHA, Matheus et al. Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: triple-blind clinical trial. Medicine, v. 100, n. 51, p. 1-7, 2021Tradução . . Disponível em: https://doi.org/10.1097/MD.0000000000028288. Acesso em: 04 jun. 2024.
APA
Bertanha, M., Rodrigues, L. da S., Mellucci Filho, P. L., Moroz, A., Pardini, M. I. de M. C., Sobreira, M. L., et al. (2021). Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: triple-blind clinical trial. Medicine, 100( 51), 1-7. doi:10.1097/MD.0000000000028288
NLM
Bertanha M, Rodrigues L da S, Mellucci Filho PL, Moroz A, Pardini MI de MC, Sobreira ML, Durigon EL, Machado RRG, Carvalho CRG. Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: triple-blind clinical trial [Internet]. Medicine. 2021 ; 100( 51): 1-7.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1097/MD.0000000000028288
Vancouver
Bertanha M, Rodrigues L da S, Mellucci Filho PL, Moroz A, Pardini MI de MC, Sobreira ML, Durigon EL, Machado RRG, Carvalho CRG. Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: triple-blind clinical trial [Internet]. Medicine. 2021 ; 100( 51): 1-7.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1097/MD.0000000000028288
Artigo de periodico
Immunodominant B cell epitope in SARS-CoV-2 RBD comprises a B.1.351 and P.1 mutation hotspot: implications for viral spread and antibody escape (2021)
Santos, Keity Souza ; Oliveira, Jamille Ramos de ; Machado, Rafael Rahal Guaragna ; Arcuri, Helen Andrade; Magawa, Jhosiene Yukari; Daher, Isabela Pazotti; Urbanski, Alysson Henrique; Schmitz, Gabriela Justamante Handel; Silva Júnior, Roberto Carlos Vieira; Durigon, Edison Luiz ; Boscardin, Silvia Beatriz ; Rosa, Daniela Santoro ; Schechtman, Deborah ; Cunha Neto, Edecio ; Gadermaier, Gabriele; Coelho, Verônica Porto Carreiro de Vasconcellos; Kalil, Jorge; Nakaya, Helder Takashi Imoto
Source: medRxiv (The Preprint Server For Health Sciences). Unidades: FM, ICB, IQ, FCF
Subjects: EPITOPOS, COVID-19, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Keity Souza et al. Immunodominant B cell epitope in SARS-CoV-2 RBD comprises a B.1.351 and P.1 mutation hotspot: implications for viral spread and antibody escape. medRxiv (The Preprint Server For Health Sciences), p. 18 , 2021Tradução . . Disponível em: https://doi.org/10.1101/2021.03.11.21253399. Acesso em: 04 jun. 2024.
APA
Santos, K. S., Oliveira, J. R. de, Machado, R. R. G., Arcuri, H. A., Magawa, J. Y., Daher, I. P., et al. (2021). Immunodominant B cell epitope in SARS-CoV-2 RBD comprises a B.1.351 and P.1 mutation hotspot: implications for viral spread and antibody escape. medRxiv (The Preprint Server For Health Sciences), 18 . doi:10.1101/2021.03.11.21253399
NLM
Santos KS, Oliveira JR de, Machado RRG, Arcuri HA, Magawa JY, Daher IP, Urbanski AH, Schmitz GJH, Silva Júnior RCV, Durigon EL, Boscardin SB, Rosa DS, Schechtman D, Cunha Neto E, Gadermaier G, Coelho VPC de V, Kalil J, Nakaya HTI. Immunodominant B cell epitope in SARS-CoV-2 RBD comprises a B.1.351 and P.1 mutation hotspot: implications for viral spread and antibody escape [Internet]. medRxiv (The Preprint Server For Health Sciences). 2021 ; 18 .[citado 2024 jun. 04 ] Available from: https://doi.org/10.1101/2021.03.11.21253399
Vancouver
Santos KS, Oliveira JR de, Machado RRG, Arcuri HA, Magawa JY, Daher IP, Urbanski AH, Schmitz GJH, Silva Júnior RCV, Durigon EL, Boscardin SB, Rosa DS, Schechtman D, Cunha Neto E, Gadermaier G, Coelho VPC de V, Kalil J, Nakaya HTI. Immunodominant B cell epitope in SARS-CoV-2 RBD comprises a B.1.351 and P.1 mutation hotspot: implications for viral spread and antibody escape [Internet]. medRxiv (The Preprint Server For Health Sciences). 2021 ; 18 .[citado 2024 jun. 04 ] Available from: https://doi.org/10.1101/2021.03.11.21253399
Artigo de periodico
Inhibition of severe acute respiratory syndrome coronavirus 2 replication by hypertonic saline solution in lung and kidney epithelial cells (2021)
Machado, Rafael Rahal Guaragna ; Glaser, Talita ; Araujo, Danielle Bastos ; Petiz, Lyvia Lintzmaier ; Durigon, Danielle Bruna Leal de Oliveira ; Durigon, Giuliana Stravinskas; Leal, Alessandra L.; Pinho, Joao Renato Rebello ; Ferreira, Luís Carlos de Souza ; Ulrich, Henning ; Durigon, Edison Luiz ; Carvalho, Cristiane Rodrigues Guzzo
Source: ACS Pharmacolology and Translational Science. Unidades: ICB, FM, IQ
Subjects: COVID-19, REPLICAÇÃO VIRAL, SAIS, MICROBIOLOGIA, CÉLULAS EPITELIAIS, CORONAVIRUS, SÍNDROME CORONARIANA AGUDA, DOENÇAS RESPIRATÓRIAS, MEMBRANA PLASMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Rafael Rahal Guaragna et al. Inhibition of severe acute respiratory syndrome coronavirus 2 replication by hypertonic saline solution in lung and kidney epithelial cells. ACS Pharmacolology and Translational Science, v. 4, n. 5, p. 1514–1527, 2021Tradução . . Disponível em: https://doi.org/10.1021/acsptsci.1c00080. Acesso em: 04 jun. 2024.
APA
Machado, R. R. G., Glaser, T., Araujo, D. B., Petiz, L. L., Durigon, D. B. L. de O., Durigon, G. S., et al. (2021). Inhibition of severe acute respiratory syndrome coronavirus 2 replication by hypertonic saline solution in lung and kidney epithelial cells. ACS Pharmacolology and Translational Science, 4( 5), 1514–1527. doi:10.1021/acsptsci.1c00080
NLM
Machado RRG, Glaser T, Araujo DB, Petiz LL, Durigon DBL de O, Durigon GS, Leal AL, Pinho JRR, Ferreira LC de S, Ulrich H, Durigon EL, Carvalho CRG. Inhibition of severe acute respiratory syndrome coronavirus 2 replication by hypertonic saline solution in lung and kidney epithelial cells [Internet]. ACS Pharmacolology and Translational Science. 2021 ; 4( 5): 1514–1527.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1021/acsptsci.1c00080
Vancouver
Machado RRG, Glaser T, Araujo DB, Petiz LL, Durigon DBL de O, Durigon GS, Leal AL, Pinho JRR, Ferreira LC de S, Ulrich H, Durigon EL, Carvalho CRG. Inhibition of severe acute respiratory syndrome coronavirus 2 replication by hypertonic saline solution in lung and kidney epithelial cells [Internet]. ACS Pharmacolology and Translational Science. 2021 ; 4( 5): 1514–1527.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1021/acsptsci.1c00080
Artigo de periodico
Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial (2021)
Santos, Paulo Sérgio da Silva ; Orcina, Bernardo da Fonseca ; Machado, Rafael Rahal Guaragna ; Vilhena, Fabiano Vieira ; Alves, Lucas Marques da Costa ; Zangrando, Mariana Schutzer Ragghianti ; Oliveira, Rodrigo Cardoso de ; Soares, Mariana Quirino Silveira ; Simão, Andréa Name Colado ; Pietro, Emilene Cristine Izu Nakamura ; Kuroda, Juliana Pescinelli Garcia ; Benjamim, Ivanilda Aparecida de Almeida; Araujo, Danielle Bastos ; Toma, Sérgio Hiroshi ; Flor, Lourival; Araki, Koiti ; Durigon, Edison Luiz
Source: Scientific Reports. Unidades: FOB, IQ, ICB
Subjects: ANTISSÉPTICOS BUCAIS, COVID-19, ANTIVIRAIS, EPIDEMIOLOGIA, MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Paulo Sérgio da Silva et al. Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial. Scientific Reports, v. 11, p. 1-10, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41598-021-99013-5. Acesso em: 04 jun. 2024.
APA
Santos, P. S. da S., Orcina, B. da F., Machado, R. R. G., Vilhena, F. V., Alves, L. M. da C., Zangrando, M. S. R., et al. (2021). Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial. Scientific Reports, 11, 1-10. doi:10.1038/s41598-021-99013-5
NLM
Santos PS da S, Orcina B da F, Machado RRG, Vilhena FV, Alves LM da C, Zangrando MSR, Oliveira RC de, Soares MQS, Simão ANC, Pietro ECIN, Kuroda JPG, Benjamim IA de A, Araujo DB, Toma SH, Flor L, Araki K, Durigon EL. Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial [Internet]. Scientific Reports. 2021 ; 11 1-10.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1038/s41598-021-99013-5
Vancouver
Santos PS da S, Orcina B da F, Machado RRG, Vilhena FV, Alves LM da C, Zangrando MSR, Oliveira RC de, Soares MQS, Simão ANC, Pietro ECIN, Kuroda JPG, Benjamim IA de A, Araujo DB, Toma SH, Flor L, Araki K, Durigon EL. Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial [Internet]. Scientific Reports. 2021 ; 11 1-10.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1038/s41598-021-99013-5
Artigo de periodico
Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing (2021)
Mendrone Junior, Alfredo ; Dinardo, Carla Luana ; Ferreira, Suzete Cleuza ; Nishya, Anna ; Salles, Nanci Alves; Almeida Neto, Cesar de ; Hamasaki, Debora Toshei; Facincani, Tila ; Alves, Lucas Bassolli de Oliveira ; Machado, Rafael Rahal Guaragna ; Araujo, Danielle Bastos ; Durigon, Edison Luiz ; Rocha, Vanderson Geraldo ; Sabino, Ester Cerdeira
Source: Transfusion. Unidades: ICB, FM
Subjects: MICROBIOLOGIA, COVID-19, IMUNOENSAIO, IMUNOGLOBULINAS, ANTICORPOS, TESTES IMUNOLÓGICOS, PLASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENDRONE JUNIOR, Alfredo et al. Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing. Transfusion, p. 10 , 2021Tradução . . Disponível em: https://doi.org/10.1111/trf.16268. Acesso em: 04 jun. 2024.
APA
Mendrone Junior, A., Dinardo, C. L., Ferreira, S. C., Nishya, A., Salles, N. A., Almeida Neto, C. de, et al. (2021). Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing. Transfusion, 10 . doi:10.1111/trf.16268
NLM
Mendrone Junior A, Dinardo CL, Ferreira SC, Nishya A, Salles NA, Almeida Neto C de, Hamasaki DT, Facincani T, Alves LB de O, Machado RRG, Araujo DB, Durigon EL, Rocha VG, Sabino EC. Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing [Internet]. Transfusion. 2021 ;10 .[citado 2024 jun. 04 ] Available from: https://doi.org/10.1111/trf.16268
Vancouver
Mendrone Junior A, Dinardo CL, Ferreira SC, Nishya A, Salles NA, Almeida Neto C de, Hamasaki DT, Facincani T, Alves LB de O, Machado RRG, Araujo DB, Durigon EL, Rocha VG, Sabino EC. Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing [Internet]. Transfusion. 2021 ;10 .[citado 2024 jun. 04 ] Available from: https://doi.org/10.1111/trf.16268
Artigo de periodico
Anti‐A and SARS‐CoV‐2: an intriguing association (2021)
Dutra, Valeria de Freitas ; Bub, Carolina Bonet ; Yokoyama, Ana Paula Hitomi ; Achkar, Ruth; Machado, Rafael Rahal Guaragna ; Assunção, Murilo; Candelelaria, Gabriela; Soares, Camila Pereira ; Fachini, Roberta Maria; Wendel, Rita Fontão; Hamerschlak, Nelson ; Reis, Luiz Fernando Lima; Araujo, Danielle Bastos ; Nudelman, Victor ; Pinho, João R. R. ; Rizzo, Luiz Vicente ; Sakashita, Araci M. ; Scuracchio, Patrícia; Durigon, Edison Luiz ; Wendel, Silvano ; Kutner, José Mauro
Source: Vox Sanguinis. Unidade: ICB
Subjects: MICROBIOLOGIA, COVID-19, GRUPOS SANGUÍNEOS, INFECÇÕES POR CORONAVIRUS, PLASMA, REAÇÃO EM CADEIA POR POLIMERASE, IMUNOGLOBULINAS, ESTUDOS DE COORTES, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUTRA, Valeria de Freitas et al. Anti‐A and SARS‐CoV‐2: an intriguing association. Vox Sanguinis, p. 7 , 2021Tradução . . Disponível em: https://doi.org/10.1111/vox.13044. Acesso em: 04 jun. 2024.
APA
Dutra, V. de F., Bub, C. B., Yokoyama, A. P. H., Achkar, R., Machado, R. R. G., Assunção, M., et al. (2021). Anti‐A and SARS‐CoV‐2: an intriguing association. Vox Sanguinis, 7 . doi:10.1111/vox.13044
NLM
Dutra V de F, Bub CB, Yokoyama APH, Achkar R, Machado RRG, Assunção M, Candelelaria G, Soares CP, Fachini RM, Wendel RF, Hamerschlak N, Reis LFL, Araujo DB, Nudelman V, Pinho JRR, Rizzo LV, Sakashita AM, Scuracchio P, Durigon EL, Wendel S, Kutner JM. Anti‐A and SARS‐CoV‐2: an intriguing association [Internet]. Vox Sanguinis. 2021 ;7 .[citado 2024 jun. 04 ] Available from: https://doi.org/10.1111/vox.13044
Vancouver
Dutra V de F, Bub CB, Yokoyama APH, Achkar R, Machado RRG, Assunção M, Candelelaria G, Soares CP, Fachini RM, Wendel RF, Hamerschlak N, Reis LFL, Araujo DB, Nudelman V, Pinho JRR, Rizzo LV, Sakashita AM, Scuracchio P, Durigon EL, Wendel S, Kutner JM. Anti‐A and SARS‐CoV‐2: an intriguing association [Internet]. Vox Sanguinis. 2021 ;7 .[citado 2024 jun. 04 ] Available from: https://doi.org/10.1111/vox.13044
Artigo de periodico
Neonatal consequences of maternal exposure to the chikungunya virus (2021)
Fajardo, Thamirys Cosmo Grillo ; Gazeta, Rosa Estela ; Catalan, Daniel Thome; Mello, Alexandra Siqueira; Silva, Andrea Cristina Botelho da; Bertozzi, Ana Paula Antunes Pascalicchio ; Santos, Geovane Ribeiro Dos ; Pinto, Clóvis Antonio Lopes; Oliveira, Cairo Monteiro de ; Machado, Rafael Rahal Guaragna ; Durigon, Danielle Bruna Leal de Oliveira ; Durigon, Edison Luiz ; Passos, Saulo Duarte
Source: Medicine. Unidade: ICB
Subjects: MICROBIOLOGIA, VÍRUS CHIKUNGUNYA, INFECÇÕES POR VÍRUS DE RNA, GRAVIDEZ, TRANSTORNOS MOTORES, TRANSTORNOS NEUROPSICOLÓGICOS, TESTES SOROLÓGICOS, RECÉM-NASCIDO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAJARDO, Thamirys Cosmo Grillo et al. Neonatal consequences of maternal exposure to the chikungunya virus. Medicine, v. 100, n. 17, p. 1-5, 2021Tradução . . Disponível em: https://doi.org/10.1097/MD.0000000000025695. Acesso em: 04 jun. 2024.
APA
Fajardo, T. C. G., Gazeta, R. E., Catalan, D. T., Mello, A. S., Silva, A. C. B. da, Bertozzi, A. P. A. P., et al. (2021). Neonatal consequences of maternal exposure to the chikungunya virus. Medicine, 100( 17), 1-5. doi:10.1097/MD.0000000000025695
NLM
Fajardo TCG, Gazeta RE, Catalan DT, Mello AS, Silva ACB da, Bertozzi APAP, Santos GRD, Pinto CAL, Oliveira CM de, Machado RRG, Durigon DBL de O, Durigon EL, Passos SD. Neonatal consequences of maternal exposure to the chikungunya virus [Internet]. Medicine. 2021 ; 100( 17): 1-5.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1097/MD.0000000000025695
Vancouver
Fajardo TCG, Gazeta RE, Catalan DT, Mello AS, Silva ACB da, Bertozzi APAP, Santos GRD, Pinto CAL, Oliveira CM de, Machado RRG, Durigon DBL de O, Durigon EL, Passos SD. Neonatal consequences of maternal exposure to the chikungunya virus [Internet]. Medicine. 2021 ; 100( 17): 1-5.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1097/MD.0000000000025695
Artigo de periodico
Case Report: A severe SARS-CoV-2 infection in a teenager with Angelman Syndrome (2021)
Lopes, Alessandra G. D. ; Celestino, Camila S. H. ; Barros, Tiago T. A.; Fevereiro, Aline G. ; Gejer, Debora H.; Oliveira, Fernando M. F.; Brasil, Jamile M. ; Bossolan, Rosely M.; Pinto, Gabriela C. C.; Santos, Ana C. E. Z.; Divan, Luis A.; Alves, Ingrid A. B.; Oliveira, Danielle Bruno Leal ; Machado, Rafael Rahal Guaragna ; Thomazelli, Luciano Matsumiya ; Hiyane, Meire Ioshie ; Abreu, Leonília Brelaz ; Jardim, Elayne Bragança ; Heinen, Letícia B. S. ; Barrientos, Anna C. M. ; Mau, Luciana Becker ; Câmara, Niels Olsen Saraiva ; Bueno, Daniela Franco ; Amano, Mariane Tami
Source: Frontiers in Medicine. Unidade: ICB
Subjects: IMUNOLOGIA, COVID-19, INFLAMAÇÃO, ANTICORPOS, SÍNDROME DE ANGELMAN, ADOLESCENTES, INFECÇÕES RESPIRATÓRIAS, INFECÇÕES POR VÍRUS DE RNA, CORONAVIRUS, VÍRUS DE RNA, INFECÇÕES POR CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Alessandra G. D. et al. Case Report: A severe SARS-CoV-2 infection in a teenager with Angelman Syndrome. Frontiers in Medicine, v. 8, p. 1-8, 2021Tradução . . Disponível em: https://doi.org/10.3389/fmed.2021.629112. Acesso em: 04 jun. 2024.
APA
Lopes, A. G. D., Celestino, C. S. H., Barros, T. T. A., Fevereiro, A. G., Gejer, D. H., Oliveira, F. M. F., et al. (2021). Case Report: A severe SARS-CoV-2 infection in a teenager with Angelman Syndrome. Frontiers in Medicine, 8, 1-8. doi:10.3389/fmed.2021.629112
NLM
Lopes AGD, Celestino CSH, Barros TTA, Fevereiro AG, Gejer DH, Oliveira FMF, Brasil JM, Bossolan RM, Pinto GCC, Santos ACEZ, Divan LA, Alves IAB, Oliveira DBL, Machado RRG, Thomazelli LM, Hiyane MI, Abreu LB, Jardim EB, Heinen LBS, Barrientos ACM, Mau LB, Câmara NOS, Bueno DF, Amano MT. Case Report: A severe SARS-CoV-2 infection in a teenager with Angelman Syndrome [Internet]. Frontiers in Medicine. 2021 ; 8 1-8.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3389/fmed.2021.629112
Vancouver
Lopes AGD, Celestino CSH, Barros TTA, Fevereiro AG, Gejer DH, Oliveira FMF, Brasil JM, Bossolan RM, Pinto GCC, Santos ACEZ, Divan LA, Alves IAB, Oliveira DBL, Machado RRG, Thomazelli LM, Hiyane MI, Abreu LB, Jardim EB, Heinen LBS, Barrientos ACM, Mau LB, Câmara NOS, Bueno DF, Amano MT. Case Report: A severe SARS-CoV-2 infection in a teenager with Angelman Syndrome [Internet]. Frontiers in Medicine. 2021 ; 8 1-8.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3389/fmed.2021.629112
Artigo de periodico
Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be? (2021)
Wendel, Silvano ; Fachini, Roberta ; Wendel, Rita C. L. Fontão; Santos, Ralyria Mello Vieira dos ; Velasquez, Carlos Vinícius; Machado, Rafael Rahal Guaragna ; Brito, Mayra Altobelli; Amaral, Marcelo; Soares, Camila Pereira ; Achkar, Ruth; Scuracchio, Patrícia ; Miyaji, Sandra Cristina; Erdens, Melina Santos; Durigon, Edison Luiz
Source: Transfusion. Unidade: ICB
Subjects: MICROBIOLOGIA, ANTIVIRAIS, COVID-19, DOADORES DE SANGUE, TESTES SOROLÓGICOS, PLASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WENDEL, Silvano et al. Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be?. Transfusion, v. 61, n. 12, p. 3455-3467, 2021Tradução . . Disponível em: https://doi.org/10.1111/trf.16714. Acesso em: 04 jun. 2024.
APA
Wendel, S., Fachini, R., Wendel, R. C. L. F., Santos, R. M. V. dos, Velasquez, C. V., Machado, R. R. G., et al. (2021). Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be? Transfusion, 61( 12), 3455-3467. doi:10.1111/trf.16714
NLM
Wendel S, Fachini R, Wendel RCLF, Santos RMV dos, Velasquez CV, Machado RRG, Brito MA, Amaral M, Soares CP, Achkar R, Scuracchio P, Miyaji SC, Erdens MS, Durigon EL. Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be? [Internet]. Transfusion. 2021 ; 61( 12): 3455-3467.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1111/trf.16714
Vancouver
Wendel S, Fachini R, Wendel RCLF, Santos RMV dos, Velasquez CV, Machado RRG, Brito MA, Amaral M, Soares CP, Achkar R, Scuracchio P, Miyaji SC, Erdens MS, Durigon EL. Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be? [Internet]. Transfusion. 2021 ; 61( 12): 3455-3467.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1111/trf.16714
Artigo de periodico
A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections (2021)
Wendel, Silvano ; Wendel, Rita Fontão; Fachini, Roberta; Candelaria, Gabriela ; Scuracchio, Patricia; Achkar, Ruth; Brito, Mayra; Reis, Luiz Fernando ; Camargo, Anamaria ; Amano, Mariane ; Machado, Rafael Rahal Guaragna ; Araujo, Danielle Bastos ; Soares, Camila Pereira ; Durigon, Edison Luiz
Source: Transfusion. Unidade: ICB
Subjects: MICROBIOLOGIA, SANGUE, PLASMA, COVID-19, ESTUDOS LONGITUDINAIS, CINÉTICA QUÍMICA, ANTICORPOS, REAÇÃO EM CADEIA POR POLIMERASE, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WENDEL, Silvano et al. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections. Transfusion, p. 14 , 2021Tradução . . Disponível em: https://doi.org/10.1111/trf.16323. Acesso em: 04 jun. 2024.
APA
Wendel, S., Wendel, R. F., Fachini, R., Candelaria, G., Scuracchio, P., Achkar, R., et al. (2021). A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections. Transfusion, 14 . doi:10.1111/trf.16323
NLM
Wendel S, Wendel RF, Fachini R, Candelaria G, Scuracchio P, Achkar R, Brito M, Reis LF, Camargo A, Amano M, Machado RRG, Araujo DB, Soares CP, Durigon EL. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections [Internet]. Transfusion. 2021 ;14 .[citado 2024 jun. 04 ] Available from: https://doi.org/10.1111/trf.16323
Vancouver
Wendel S, Wendel RF, Fachini R, Candelaria G, Scuracchio P, Achkar R, Brito M, Reis LF, Camargo A, Amano M, Machado RRG, Araujo DB, Soares CP, Durigon EL. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections [Internet]. Transfusion. 2021 ;14 .[citado 2024 jun. 04 ] Available from: https://doi.org/10.1111/trf.16323
Artigo de periodico
COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes (2021)
Yokoyama, Ana Paula Hitomi ; Wendel, Silvano ; Bub, Carolina Bonet ; Fachini, Roberta M.; Dametto, Ana Paula F.; Blumm, Fernando; Dutra, Valeria F. ; Candelaria, Gabriela T. P. ; Sakashita, Araci M.; Machado, Rafael Rahal Guaragna ; Wendel, Rita Fontão; Hamerschlak, Nelson ; Achkar, Ruth; Assunção, Murillo Santucci Cesar ; Scuracchio, Patrícia; Nudelman, Victor; Pastore, Laerte; Pinho, João R. R.; Ben, Mirian Dal; Kalil Filho, Roberto ; Marra, Alexandre R.; Amano, Mariane T. ; Kallás, Esper Georges ; Helito, Alfredo Salim; Carvalho, Carlos Roberto Ribeiro De ; Araujo, Danielle Bastos ; Durigon, Edison Luiz ; Camargo, Anamaria Aranha ; Rizzo, Luiz V. ; Reis, Luiz F. L. ; Kutner, José Mauro
Source: Transfusion. Unidades: FM, ICB
Subjects: MICROBIOLOGIA, COVID-19, TRANSFUSÃO DE SANGUE, PLASMA, ANTICORPOS, ESTUDOS DE COORTES, PACIENTES, UNIDADES DE TERAPIA INTENSIVA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YOKOYAMA, Ana Paula Hitomi et al. COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes. Transfusion, p. 1-12, 2021Tradução . . Disponível em: https://doi.org/10.1111/trf.16573. Acesso em: 04 jun. 2024.
APA
Yokoyama, A. P. H., Wendel, S., Bub, C. B., Fachini, R. M., Dametto, A. P. F., Blumm, F., et al. (2021). COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes. Transfusion, 1-12. doi:10.1111/trf.16573
NLM
Yokoyama APH, Wendel S, Bub CB, Fachini RM, Dametto APF, Blumm F, Dutra VF, Candelaria GTP, Sakashita AM, Machado RRG, Wendel RF, Hamerschlak N, Achkar R, Assunção MSC, Scuracchio P, Nudelman V, Pastore L, Pinho JRR, Ben MD, Kalil Filho R, Marra AR, Amano MT, Kallás EG, Helito AS, Carvalho CRRD, Araujo DB, Durigon EL, Camargo AA, Rizzo LV, Reis LFL, Kutner JM. COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes [Internet]. Transfusion. 2021 ; 1-12.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1111/trf.16573
Vancouver
Yokoyama APH, Wendel S, Bub CB, Fachini RM, Dametto APF, Blumm F, Dutra VF, Candelaria GTP, Sakashita AM, Machado RRG, Wendel RF, Hamerschlak N, Achkar R, Assunção MSC, Scuracchio P, Nudelman V, Pastore L, Pinho JRR, Ben MD, Kalil Filho R, Marra AR, Amano MT, Kallás EG, Helito AS, Carvalho CRRD, Araujo DB, Durigon EL, Camargo AA, Rizzo LV, Reis LFL, Kutner JM. COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes [Internet]. Transfusion. 2021 ; 1-12.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1111/trf.16573
Artigo de periodico
Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program (2020)
Wendel, Silvano ; Kutner, José Mauro ; Machado, Rafael Rahal Guaragna ; Wendel, Rita Fontão; Bub, Carolina ; Fachini, Roberta; Yokoyama, Ana ; Candelaria, Gabriela ; Sakashita, Araci ; Achkar, Ruth; Hamerschlak, Nelson ; Scuracchio, Patricia; Amaral, Marcelo; Ben, Mirian Dal; Araujo, Danielle Bastos ; Soares, Camila Pereira ; Camargo, Anamaria ; Kallás, Esper Georges ; Durigon, Edison Luiz ; Reis, Luiz Fernando ; Rizzo, Luiz Vicente
Source: Transfusion. Unidades: FM, ICB
Subjects: MICROBIOLOGIA, IMUNOTERAPIA, PLASMA, ANTICORPOS, TRIAGEM, REAÇÃO EM CADEIA POR POLIMERASE, ADJUVANTES IMUNOLÓGICOS, IMUNOGLOBULINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WENDEL, Silvano et al. Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program. Transfusion, p. 1-4, 2020Tradução . . Disponível em: https://doi.org/10.1111/trf.16065. Acesso em: 04 jun. 2024.
APA
Wendel, S., Kutner, J. M., Machado, R. R. G., Wendel, R. F., Bub, C., Fachini, R., et al. (2020). Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program. Transfusion, 1-4. doi:10.1111/trf.16065
NLM
Wendel S, Kutner JM, Machado RRG, Wendel RF, Bub C, Fachini R, Yokoyama A, Candelaria G, Sakashita A, Achkar R, Hamerschlak N, Scuracchio P, Amaral M, Ben MD, Araujo DB, Soares CP, Camargo A, Kallás EG, Durigon EL, Reis LF, Rizzo LV. Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program [Internet]. Transfusion. 2020 ; 1-4.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1111/trf.16065
Vancouver
Wendel S, Kutner JM, Machado RRG, Wendel RF, Bub C, Fachini R, Yokoyama A, Candelaria G, Sakashita A, Achkar R, Hamerschlak N, Scuracchio P, Amaral M, Ben MD, Araujo DB, Soares CP, Camargo A, Kallás EG, Durigon EL, Reis LF, Rizzo LV. Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program [Internet]. Transfusion. 2020 ; 1-4.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1111/trf.16065

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Grupo de pesquisa

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration